- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '77080'
    - '77081'
    - '77085'
    - '77086'
  conditions:
    any_of:
    - min_age: 65
    - dx_in_value_set: vs_osteoporosis_risk_factors_2025_09
    - dx_in_value_set: vs_fracture_history_2025_09
    - has_flag: postmenopausal_women_age_50_64
    all_of:
    - has_flag: osteoporosis_screening_indicated
    none_of:
    - has_flag: dexa_scan_within_2_years
  logic:
    outcome: PA_REQUIRED
    note: DEXA bone density scan for osteoporosis screening and fracture risk assessment
      in women 65+ postmenopausal women 50-64 with risk factors or fracture history
      with dual-energy X-ray absorptiometry
  precedence: 80
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_osteoporosis_screening_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_212579d6f120
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    ndc:
    - 00078047915
    - 00078047975
    - '55513019401'
  conditions:
    any_of:
    - dx_in_value_set: vs_osteoporosis_2025_09
    - dx_in_value_set: vs_osteopenia_high_risk_2025_09
    - dx_in_value_set: vs_glucocorticoid_induced_osteoporosis_2025_09
    all_of:
    - has_flag: dexa_t_score_minus_2_5_or_lower
    none_of:
    - has_flag: esophageal_disorders
    - has_flag: hypocalcemia
    - has_flag: inability_to_stand_sit_upright
  logic:
    outcome: PA_REQUIRED
    note: "Bisphosphonate therapy for osteoporosis treatment and fracture prevention\
      \ with T-score \u2264-2.5 or high fracture risk excluding esophageal disorders\
      \ with oral antiresorptive agents"
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_osteoporosis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_10332e7f816e
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J0897
  conditions:
    any_of:
    - dx_in_value_set: vs_osteoporosis_severe_2025_09
    - dx_in_value_set: vs_bisphosphonate_intolerant_2025_09
    all_of:
    - has_flag: high_fracture_risk
    - has_flag: bisphosphonate_contraindicated_or_failed
    none_of:
    - has_flag: hypocalcemia
    - has_flag: immunocompromised
  logic:
    outcome: PA_REQUIRED
    note: Denosumab therapy for severe osteoporosis with bisphosphonate intolerance
      or bisphosphonate intolerance with high fracture risk using RANKL inhibitor
      subcutaneous injection
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_osteoporosis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_36a71c7655dc
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3110
  conditions:
    any_of:
    - dx_in_value_set: vs_osteoporosis_severe_2025_09
    - dx_in_value_set: vs_glucocorticoid_osteoporosis_severe_2025_09
    all_of:
    - has_flag: multiple_fractures_or_very_high_risk
    - has_flag: antiresorptive_therapy_inadequate
    none_of:
    - has_flag: paget_disease
    - has_flag: bone_metastases
    - has_flag: prior_radiation_therapy
  logic:
    outcome: PA_REQUIRED
    note: Teriparatide therapy for severe osteoporosis with fractures and anabolic
      bone formation multiple fractures when antiresorptive therapy inadequate using
      recombinant human parathyroid hormone
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_osteoporosis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_b11ed043e047
